neutralizing tumor-promoting chronic inflammation: magic bullet 
substantial advances cancer diagnostics therapies past decade besides chemotherapeutic agents radiation therapy approaches now include targeting cancer cell-intrinsic mediators linked genetic aberrations cancer cells addition cancer cell-extrinsic pathways especially regulating vascular programming solid tumors recently immunotherapeutics entered clinic largely basis recognition several immune cell subsets chronically activated foster tumor development discuss clinical experimental studies delineating protumorigenic roles immune cell subsets players cancer-associated inflammation cells can targeted reprogram function leading resolution least neutralization cancer-promoting chronic inflammation thereby facilitating cancer rejection 
